Desmopressin may be hazardous in thrombotic microangiopathy

Nephrology Dialysis Transplantation

Volumn 16, Issue 1, 2001, Pages 161-162

  Stratton, Jon ^a   Warwicker, Paul ^a   Watkins, Sylvia ^a   Farrington, Ken ^a  

^a LISTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOPHOSPHAMIDE; DESMOPRESSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; MITOMYCIN C; MITOXANTRONE; QUININE SULFATE; TAMOXIFEN;

ACUTE HEART INFARCTION; ANEMIA; ARTICLE; BLEEDING TIME; BLOOD TRANSFUSION; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CASE REPORT; DISEASE COURSE; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; KIDNEY BIOPSY; KIDNEY FUNCTION; MASTECTOMY; PRIORITY JOURNAL; SINUS BRADYCARDIA; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0035168515     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.1.161     Document Type: Article

References (7)

1. An audit of appropriate tests in renal biopsy coagulation screens
2. A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndrome
3. Quinine induced immune thrombocytopenia purpura followed by hemolytic uremic syndrome
4. Desmopressin and myocardial infarction
5. Desmopressin and myocardial infarction
6. Haemolytic uraemic syndrome
7. Abnormal VIII: Von Willebrand factor patterns in the plasma of patients with the hemolytic uremic syndrome